Pfizer, Inc. (PFE)

NYSEHealthcare

$28.33
-$0.22 (-0.8%)
Market closed

April 2, 2026 at 20:00 UTC

Interactive Chart

PFE
1H
3H
6H
12H
1D
1W
1M
3M
6M
1Y
2Y
5Y
All

16:56:14 UTC

About Pfizer, Inc.

Name
Pfizer, Inc.
CEO
Albert Bourla
Industry
Healthcare
Year Founded
1849
Employees
81,000

Pfizer, Inc. is a pharmaceutical company that discovers, develops, and supplies medicines and vaccines used in clinical practice worldwide. The operating model links science with delivery: research feeds trials, approvals lead to scaled production, and medical education supports appropriate use. Manufacturing and quality systems favor continuity, so once therapies enter practice, supply stays steady. Field teams focus on safety, labeling clarity, and guidance that fits real workflows in hospitals and clinics. Access programs and country teams adapt to local rules while holding to common standards. The goal is simple and long-term: turn evidence into dependable options that clinicians can trust and patients can live with. Within healthcare, Pfizer’s role is to make new treatments feel workable in daily care.

Analyst Ratings

Consensus Recommendation
Analyst consensus: 14 Buy, 7 Hold, 2 Sell
Buy14
Hold7
Sell2

Fundamentals & Financials

Revenue (TTM)
$62.5B
Net Income (TTM)
$7.7B
EPS (TTM)
$1.36
ROA (TTM)
3.73%
Current Ratio
1.16
Dividend Yield
0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

ItemQ4 2025
Revenue$17,557M
Cost of Sales$5,272M
Gross Profit$12,285M
Operating Income$3,688M
Net Income-$1,648M
EPS-$0.29

Technical Indicators

Pfizer, Inc.'s Technical Indicators Summary

Pfizer exhibits a bullish technical profile with price around $28.3 trading above short-, medium- and long-term moving averages, signaling broad upward alignment. Momentum is generally positive—RSI in the low 60s, a high CCI and a positive MACD—although the stochastic is overbought, suggesting near-term caution. ADX below 20 points to limited trend strength, while ATR is low at about $0.63 and OBV indicates strong accumulation. The pivot level is close to the price and Bollinger bands show contained range. Technical takeaway: bullish—broad moving-average support and volume backing despite short-term overbought readings.

Buy
14 signals
Neutral
7 signals
Sell
2 signals
Overall: Bullish61% Bullish signals
IndicatorValue
RSI (14)
61.63
Stochastic %K (14, 3, 3)
88.33
CCI (20)
197.22
WPR (14)
-18.61
Momentum (10)
0.91
MFI
58.30
MACD Level (12, 26)
0.33
Bollinger Bands
$26.20 - $28.38
ATR (14)
$0.63 (2.21%)
ADX (14)
18.06
OBV
877,945,800
Classic Pivot Point
$28.41
Fibonacci Pivot Point
$28.41
Exponential Moving Averages
$25.50 - $27.74(5 indicators)
Simple Moving Averages
$25.46 - $27.53(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day concluded on a slightly softer note, with PFE maintaining a small -0.81% downside gap and finishing at about 28.32. Into the close, PFE still showed subdued interest, with volume at 0.53× its norm. PFE slides modestly as Pfizer faces a disability-bias suit, with light volume signaling tepid interest.

Price Change

from $28.33 close

+$0.01

Trading Volume

Below avg (40.8M)

21.4M

vs S&P 500 Today

Moderate Underperformance

-0.34%

52-Week Position

Near highs

94.5%

Updated: April 3, 2026 at 20:03 UTC

Quote Summary

OpenPrevious Close
$28.5$28.33
Day Range52 Week Range
$28.22 - $28.75$20.92 - $28.75
VolumeAvg. Volume
21.4M45.9M
Market CapP/E Ratio
$161B20.8